הA conference, which will be held on June 30 in Herzliya by the American investors club silicomventures, will present the latest innovations in the field of personalized medicine, with the participation of the main researchers involved in the field, including many Israelis
The PMWC (Personalized Medicine World Conference) dealing with personalized medicine is coming to Israel for the second time from Silicon Valley in the USA. At the conference, which will be held on June 30 at the Daniel Hotel in Herzliya, innovations, market trends and current research in the field of personalized medicine will be presented. Among the aspects that will be presented are pharmacogenetics, molecular diagnostics, personalized oncology, as well as technological developments for processing this multidimensional information.
As part of the conference, aspects of ethics and regulation will also be discussed, as well as pioneering and promising start-up companies in the field will be presented. The conference is a business-scientific platform for the promotion, development and implementation of applications in the field of personalized medicine in Israel and worldwide, and is intended for stakeholders from the business, technological, medical and academic sectors.
The conference held by the American investors club "Silicom Ventures" (silicomventures), attracts key people and executives in the industry from Israel and abroad. Among the speakers at the conference: Neil de Crescenzo, vice president of Oracle Health Sciences, Vance Vanier, vice president of Verinata Health, Roman Yelensky, director, Foundation Medicine, Sushma Selbarhan, director of development and strategy, Roche Molecular Systems
Chairman of the PMWC ISRAEL 2013 conference, Dr. Iris Grossman, senior manager of the unit that specializes in personalized medicine and pharmacogenetics at "Teva": "Personalized medicine" is a broad field, which brings together a very wide range of scientific discoveries, technological developments and regulatory applications, and is characterized by a strong involvement of the patients and the health systems as a whole. The products that reach the market are the result of collaborations between different disciplines and different service providers, which come together to provide a creative and reliable solution to medical deficiencies. The conference program PMWC ISRAEL 2013 was built with the recognition that many fields are involved in the field and that dialogue is the recipe for success. That's why we chose leading speakers in their field who will represent the many faces of personalized medicine and share with the audience their experience and recommendations for the next generation of successes in personalized medicine"
At each PMWC conference, a badge of honor is awarded to a person whose leadership and vision have contributed significantly to the advancement of the field of personalized medicine. This year, the award will be given to Kim Popovitz, who serves as chairman-CEO-president of Genomic Health. Popovitz broke through when she was able to translate a scientific discovery into the development of a commercial test. Genomic Health's oncotype test was one of the first tests to enter medical use and is still one of the cornerstones of personalized medicine.
